IL-15 enhances immune functions during HIV infection

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Interleukin-15 (IL-15) shares functional properties with Interleukin-2 (IL-2).
• HIV infection often leads to impaired immune cell function, including reduced Natural Killer (NK) cell activity.

Purpose of the Study:

• To investigate the effects of IL-15 on immune cells from HIV-infected individuals.
• To assess IL-15's potential to restore NK cell cytotoxicity and T-cell proliferation in the context of HIV.

Main Methods:

• Peripheral Blood Mononuclear Cells (PBMC) from HIV-positive patients and healthy donors were treated with IL-15.
• NK cell cytotoxicity, granule expression, and cell proliferation were measured.
• The impact of IL-15 on spontaneous and induced apoptosis was evaluated.
• IL-15 and IL-12 production in response to Staphylococcus aureus Cowan strain 1 was assessed.

Main Results:

• IL-15 treatment significantly increased NK cell cytotoxicity in HIV-PBMC to levels comparable to healthy donors.
• Enhanced cytotoxicity correlated with increased cytotoxic granule expression.
• IL-15 improved T-cell proliferation in response to mitogens and recall antigens.
• IL-15 partially prevented spontaneous cell death but not mitogen-induced apoptosis.
• IL-15 restored deficient IL-12 production in PBMC from HIV-positive individuals.

Conclusions:

• IL-15 demonstrates potent immunoregulatory effects in HIV infection.
• It enhances NK cell function and T-cell proliferation, offering a potential therapeutic avenue.
• IL-15's ability to restore IL-12 production is a significant finding for immune restoration in HIV.